Agneta H. Snoer

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical Trial.

Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical Trial.

Journal: JAMA neurology

Published: May 19, 2025

PACAP-38 in Cluster Headache: A Prospective, Case-Control Study of a Potential Treatment Target.

PACAP-38 in Cluster Headache: A Prospective, Case-Control Study of a Potential Treatment Target.

Journal: European journal of neurology

Published: April 25, 2025

Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.

Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.

Journal: The Lancet. Neurology

Published: November 08, 2024

Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study.

Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study.

Journal: Annals of neurology

Published: September 24, 2024

Compensated Hypogonadism Identified in Males with Cluster Headache: A Prospective Case-Controlled Study.

Compensated Hypogonadism Identified in Males with Cluster Headache: A Prospective Case-Controlled Study.

Journal: Annals of neurology

Published: December 04, 2023

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study.

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study.

Journal: Frontiers in neurology

Published: December 31, 2022

Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache.

Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache.

Journal: Cephalalgia : an international journal of headache

Published: October 21, 2022

Corrigendum to: PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.

Corrigendum to: PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.

Journal: Cephalalgia : an international journal of headache

Published: May 13, 2022

The economic and personal burden of cluster headache: a controlled cross-sectional study.

The economic and personal burden of cluster headache: a controlled cross-sectional study.

Journal: The journal of headache and pain

Published: March 29, 2022

Intranasal treatment of cluster headache: A response.

Intranasal treatment of cluster headache: A response.

Journal: Headache

Published: February 03, 2022

Frequent or chronic migraine negatively impacts personal, social and professional life.

Frequent or chronic migraine negatively impacts personal, social and professional life.

Journal: Danish medical journal

Published: January 05, 2022

PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.

PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.

Journal: Cephalalgia : an international journal of headache

Published: November 25, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026